Key result
Calpain inhibition with MDL-7943 during early reperfusion prevented the 80% reduction in Na+/K+-ATPase activity and attenuated cell death in isolated rat hearts.
Why the study?
Does calpain inhibition with MDL-7943 prevent Na+/K+-ATPase impairment and cell death in isolated rat hearts during early reperfusion after myocardial ischemia?
Does calpain inhibition with MDL-7943 prevent Na+/K+-ATPase impairment and cell death in isolated rat hearts during early reperfusion after myocardial ischemia?
Calpain activation during early reperfusion degrades the anchorage of Na+/K+-ATPase to the membrane cytoskeleton, contributing to its impairment and subsequent cell death.
Answers are grounded in this paper and cite their sources.
Calpain inhibition merits testing in larger reperfusion models; leaves open any role in human cardioprotection.
Na+ overload and secondary Ca2+ influx via Na+/Ca2+ exchanger are key mechanisms in cardiomyocyte contracture and necrosis during reperfusion. Impaired Na+/K+-ATPase activity contributes to Na+ overload, but the mechanism has not been established. Because Na+/K+-ATPase is connected to the cytoskeleton protein fodrin through ankyrin, which are substrates of calpains, we tested the hypothesis that calpain mediates Na+/K+-ATPase impairment in reperfused cardiomyocytes. In isolated rat hearts reperfused for 5 minutes after 60 minutes of ischemia, Na+/K+-ATPase activity was reduced by 80%, in parallel with loss of alpha-fodrin and ankyrin-B and detachment of alpha1 and alpha2 subunits of Na+/K+-ATPase from the membrane-cytoskeleton complex. Calpain inhibition with MDL-7943 during reperfusion prevented the loss of these proteins, increased Na+/K+-ATPase activity, attenuated lactate dehydrogenase release, and improved contractile recovery, and these beneficial effects of MDL-7943 were reverted by ouabain. The impairment of Na+/K+-ATPase was not a mere consequence of cell death because it was not altered in hearts in which contracture and cell death had been prevented by contractile blockade with 2,3-butanedione monoxime. In these hearts, concomitant calpain inhibition preserved Na+/K+-ATPase content and function and attenuated cell death occurring on withdrawal of 2,3-butanedione monoxime. In vitro assay showed no detectable degradation of Na+/K+-ATPase subunits after 10 minutes of incubation with activated calpain. Thus, we conclude that calpain activation contributes to the impairment of Na+/K+-ATPase during early reperfusion and that this effect is mainly mediated by degradation of the anchorage of Na+/K+-ATPase to the membrane cytoskeleton.
No takes yet. Share an insight, caveat, or question.
Inserte et al. (2005) studied Myocardial ischemia and reperfusion injury. MDL-7943 (calpain inhibitor) vs. No calpain inhibition (implied) was evaluated on Na+/K+-ATPase activity and cell death. Calpain inhibition with MDL-7943 during early reperfusion prevented the 80% reduction in Na+/K+-ATPase activity and attenuated cell death in isolated rat hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: